Broadwood adds 182,861 Insight Molecular shares
Insight Molecular Diagnostics Inc. shareholder entities associated with Broadwood Partners, L.P. and Neal C. Bradsher reported open-market purchases of 182,861 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Insight Molecular Diagnostics Inc. shareholder entities associated with Broadwood Partners, L.P. and Neal C. Bradsher reported open-market purchases of 182,861 shares of common stock. The shares were bought between April 16 and April 20 at weighted average prices of $3.4457, $3.5711, and $3.8822 per share, across specified price ranges disclosed in the footnotes.
Following these transactions, Broadwood Partners is shown with 12,114,700 indirectly owned Insight Molecular common shares, while Neal C. Bradsher directly owns a small additional common stock position. The filing also lists currently exercisable warrants, held both directly and indirectly, each for 150,093 underlying shares at an exercise price of $30.60 per share expiring on April 19, 2027.
Insider Trade Summary
Net Buyer: 182,861 shares
Net Buy
9 txns
Insider
BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC, Bradsher Neal C
Role
10% Owner | 10% Owner | 10% Owner
Bought
182,861 shs ($653K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, no par value | 40,690 | $3.8822 | $158K |
| Purchase | Common Stock, no par value | 0 | $0.00 | $0.00 |
| Purchase | Common Stock, no par value | 40,114 | $3.5711 | $143K |
| Purchase | Common Stock, no par value | 0 | $0.00 | $0.00 |
| Purchase | Common Stock, no par value | 102,057 | $3.4457 | $352K |
| Purchase | Common Stock, no par value | 0 | $0.00 | $0.00 |
| holding | Warrant to Purchase Common Stock | -- | -- | -- |
| holding | Warrant to Purchase Common Stock | -- | -- | -- |
| holding | Common Stock, no par value | -- | -- | -- |
Holdings After Transaction:
Common Stock, no par value — 12,114,857 shares (Direct);
Common Stock, no par value — 12,114,700 shares (Indirect, Footnote);
Warrant to Purchase Common Stock — 150,093 contracts (Direct);
Warrant to Purchase Common Stock — 150,093 contracts (Indirect, Footnote)
Footnotes (6)
- F1. The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be beneficially owned by each of: (i) Broadwood Capital, Inc. ("Broadwood Capital"), as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher, as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- F2. These securities are directly owned by Neal C. Bradsher.
- F3. This constitutes the weighted average purchase price. The prices range from $3.20 to $3.59. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- F4. This constitutes the weighted average purchase price. The prices range from $3.45 to $3.84. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- F5. This constitutes the weighted average purchase price. The prices range from $3.75 to $3.99. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- F6. These warrants are currently exercisable.
Key Figures
Net shares purchased: 182,861 shares
Weighted average price 16 Apr 2026: $3.4457/share
Weighted average price 17 Apr 2026: $3.5711/share
+5 more
8 metrics
Net shares purchased
182,861 shares
Open-market common stock buys between April 16–20, 2026
Weighted average price 16 Apr 2026
$3.4457/share
Purchase of 102,057 common shares
Weighted average price 17 Apr 2026
$3.5711/share
Purchase of 40,114 common shares
Weighted average price 20 Apr 2026
$3.8822/share
Purchase of 40,690 common shares
Indirect common shares after trades
12,114,700 shares
Common stock indirectly owned by Broadwood Partners after purchases
Direct common shares holding entry
157 shares
Direct common stock position shown as of April 16, 2026
Warrant exercise price
$30.60/share
Warrants on 150,093 underlying shares held directly and 150,093 indirectly
Warrant expiration
April 19, 2027
Expiration date for listed Insight Molecular warrants
Key Terms
open-market purchase, weighted average purchase price, pecuniary interest, warrants, +1 more
5 terms
open-market purchase financial
"transaction_action: "open-market purchase" for common stock buys"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average purchase price financial
"Footnotes F3, F4, and F5 describe the prices as "weighted average purchase price""
The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.
pecuniary interest financial
"Footnote F1 states each Reporting Person disclaims beneficial ownership except to the extent of its or his pecuniary interest"
warrants financial
"Security titled "Warrant to Purchase Common Stock" with currently exercisable status"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
beneficial ownership financial
"Footnote F1 notes securities may be deemed to be beneficially owned by Broadwood Capital and Neal C. Bradsher"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is attributed ownership of the reported IMDX securities in this Form 4?
The common shares are directly owned by Broadwood Partners, L.P., and some are directly owned by Neal C. Bradsher. Footnotes state other reporting persons may be deemed beneficial owners but disclaim ownership except to the extent of their pecuniary interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates